Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies
Heitor O. Santos, Richard Kones, Umme Rumana, et al.
Clinical Therapeutics (2019) Vol. 41, Iss. 9, pp. 1780-1797
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis
Haiyan Meng, Lei Zhu, Hamed Kord‐Varkaneh, et al.
Nutrition (2020) Vol. 77, pp. 110801-110801
Closed Access | Times Cited: 117
Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers—An Overview
Heitor O. Santos, James C. Price, Allain Amador Bueno
Nutrients (2020) Vol. 12, Iss. 10, pp. 3159-3159
Open Access | Times Cited: 107
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
Byambaa Enkhmaa, Kristina H. Petersen, Penny M. Kris‐Etherton, et al.
Nutrients (2020) Vol. 12, Iss. 7, pp. 2024-2024
Open Access | Times Cited: 72
Effects of time-restricted feeding (16/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: A randomized controlled trial
Hamed Kord‐Varkaneh, Ammar Salehi‐Sahlabadi, Grant M. Tinsley, et al.
Nutrition (2022) Vol. 105, pp. 111847-111847
Closed Access | Times Cited: 49
Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
Hamed Kord‐Varkaneh, Ammar Salehi sahlabadi, Mihnea‐Alexandru Găman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 43
The effect of vitamin D on the lipid profile as a risk factor for coronary heart disease in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials
Wen Zhang, Jian Yi, Dan Liu, et al.
Experimental Gerontology (2022) Vol. 161, pp. 111709-111709
Closed Access | Times Cited: 42
Eating more sardines instead of fish oil supplementation: Beyond omega-3 polyunsaturated fatty acids, a matrix of nutrients with cardiovascular benefits
Heitor O. Santos, Theresa L. May, Allain Amador Bueno
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 24
Weight loss and its influence on high-density lipoprotein cholesterol (HDL-C) concentrations: A noble clinical hesitation
Heitor O. Santos, Carl J. Lavie
Clinical Nutrition ESPEN (2021) Vol. 42, pp. 90-92
Closed Access | Times Cited: 43
Coconut oil intake and its effects on the cardiometabolic profile – A structured literature review
Heitor O. Santos, Scott Howell, Conrad P. Earnest, et al.
Progress in Cardiovascular Diseases (2019) Vol. 62, Iss. 5, pp. 436-443
Closed Access | Times Cited: 41
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
A.-D. Koutsogianni, Georgé Liamis, Evangelos Liberopoulos, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 750-750
Open Access | Times Cited: 12
Is breakfast consumption detrimental, unnecessary, or an opportunity for health promotion? A review of cardiometabolic outcomes and functional food choices
Heitor O. Santos, Grant M. Tinsley
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 2
Closed Access | Times Cited: 11
The effect of highly bioavailable forms of curcumin on lipoprotein(a) plasma levels: a systematic review and meta-analysis of randomized clinical studies
Federica Fogacci, Ashot Avagimyan, Arturo Cesaro, et al.
Prostaglandins & Other Lipid Mediators (2025) Vol. 178, pp. 106994-106994
Open Access
Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods
Federica Fogacci, Valentina Di Micoli, Ashot Avagimyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13886-13886
Open Access | Times Cited: 10
Revisiting the concepts of de novo lipogenesis to understand the conversion of carbohydrates into fats: stop overvaluing and extrapolating the renowned phrase "fat burns in the flame of carbohydrate"
Heitor O. Santos, Nilson Penha‐Silva
Nutrition (2024) Vol. 130, pp. 112617-112617
Closed Access | Times Cited: 3
The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials
Sara Abdulrahman Alomar, Mihnea‐Alexandru Găman, Kousalya Prabahar, et al.
Experimental Gerontology (2021) Vol. 159, pp. 111680-111680
Closed Access | Times Cited: 23
Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus
Marcello Ricardo Paulista Markus, Till Ittermann, Sabine Schipf, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 18
The effects of coconut oil on the cardiometabolic profile: a systematic review and meta-analysis of randomized clinical trials
Ana Cláudia Duarte, Bernardo Frison Spiazzi, Carolina Pires Zingano, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Intermittent Fasting and Fat Mass: What Is the Clinical Magnitude?
Heitor O. Santos
Obesities (2022) Vol. 2, Iss. 1, pp. 1-7
Open Access | Times Cited: 13
Effects of intermittent fasting combined with physical exercise on cardiometabolic outcomes: systematic review and meta-analysis of clinical studies
Fatemeh Kazeminasab, Maryam Baharlooie, Bahareh Karimi, et al.
Nutrition Reviews (2023) Vol. 82, Iss. 12, pp. 1726-1740
Closed Access | Times Cited: 7
The effect of tibolone treatment on lipid profile in women: A systematic review and dose-response meta-analysis of randomized controlled trials
Changyu Lv, Wencui Zhang, Xia Tan, et al.
Pharmacological Research (2021) Vol. 169, pp. 105612-105612
Closed Access | Times Cited: 15
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
Peter E. Penson, Maciej Banach
Current Atherosclerosis Reports (2020) Vol. 22, Iss. 11
Open Access | Times Cited: 16
Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting
Arrigo F.G. Cicero, Federica Fogacci, Marina Giovannini, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3289-3289
Open Access | Times Cited: 5
Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients
Zahra Yari, Hadi Tabibi, Iraj Najafi, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 8, pp. 1382-1388
Closed Access | Times Cited: 14
Review of Isoflavones and Their Potential Clinical Impacts on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
Zahra Yari
Preventive Nutrition and Food Science (2022) Vol. 27, Iss. 4, pp. 347-353
Open Access | Times Cited: 8
Increased cardiovascular risk associated to hyperlipoproteinemia (a) and the challenges of current and future therapeutic possibilities
Zlatko Fras
The Anatolian Journal of Cardiology (2019)
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top